issued
on 03 Sep 2024
Last Applicant/ Owned by
4428 lingan rd Nw
Washington
DC
20007
Serial Number
98134533 filed on 15th Aug 2023
Registration Number
N/A
Correspondent Address
Phillip Thomas Horton
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Research and development and consultation related thereto in the field of healthcare and education; Consulting services for others in the field of design, planning, and implementation project management of software and scientific services, clinical research, conducting clinical trials Advertising services; Business consulting services; On-line retail store services featuring heathcare goods Educ Read More
Research and development and consultation related thereto in the field of healthcare and education; Consulting services for others in the field of design, planning, and implementation project management of software and scientific services, clinical research, conducting clinical trials
N/A
N/A
Educational services, namely, providing classes, seminars, workshops in the fields of software and scientific services, clinical research, clinical trials, strategic planning, business case modeling, telehealth and digital deployment, digital health venture and investment, digital health education
N/A
N/A
Advertising services; Business consulting services; On-line retail store services featuring heathcare goods
N/A
N/A
No 98134533
No Service Mark
No
No
No
No
No
No
No
No
No
26.01.06 -
Semi-circles
26.01.13 -
Two circles
26.01.16 -
Circles touching or intersecting
Status Date | Action Taken |
---|---|
03rd Sep 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
09th Jul 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
09th Jul 2024 | PUBLISHED FOR OPPOSITION |
19th Jun 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
03rd Jun 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
31st May 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
31st May 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
31st May 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
23rd Apr 2024 | NON-FINAL ACTION E-MAILED |
23rd Apr 2024 | NON-FINAL ACTION WRITTEN |